PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 31, 2026Molecules0 citationsOpen Access

E/Z Isomerism of the Potential Antiepileptic Drug GIZH-298

View Full Paper
ГМГ. В. МокровSLSvetlana A. LitvinovaVBV. E. Biryukova

Key Points

  • This research aims to synthesize and characterize the E- and Z-isomers of GIZH-298, assessing their potential as anticonvulsants.
  • Synthesis and purification of E- and Z-isomers of GIZH-298
  • Characterization through physicochemical and spectral analysis
  • Evaluation of anticonvulsant activity using the maximal electroshock assay.
  • Z-GIZH-298 exhibits higher anticonvulsant efficacy compared to E-GIZH-298.
  • Z-GIZH-298 is photosensitive, undergoing Z-E isomerization upon irradiation.
  • Partial conversion to the E-form during reflux in polar solvents was observed, while stability is maintained in aqueous conditions.

Abstract

The synthesis, purification, and comprehensive characterization of the E- and Z-isomers of the prospective anticonvulsant compound GIZH-298 were carried out. It was demonstrated that both isomers could be obtained in a pure form by isolating the corresponding oximes at the initial stage of synthesis. The E- and Z-isomers exhibit pronounced differences in their physicochemical characteristics, spectral features, and pharmacological profiles. Z-GIZH-298 was found to be photosensitive, undergoing Z-E isomerization upon irradiation, as confirmed by both theoretical analysis and experimental observations. Additionally, partial conversion to the E-form occurs during prolonged reflux of Z-GIZH-298 in polar solvents, whereas the compound remains stable in aqueous and acidic media at ambient temperature. In the maximal electroshock assay, both isomers demonstrated anticonvulsant activity, with Z-GIZH-298 showing substantially higher efficacy than its E-counterpart. These findings highlight the need to account for potential E-isomer formation when considering further development of Z-GIZH-298 as a promising anticonvulsant agent.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Мокров et al. (2026) studied this question.

synapsesocial.com/papers/6a1bd1db5783ba022b6fd3f9https://doi.org/10.3390/molecules31111872
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Integrating Synthesis, Pharmacological Activity, and Molecular Modeling to Explore 1,2,4-Triazine Fused Thiazolidin-4-one Derivatives as GABAA Receptor Modulators2026
  2. 2Design, Synthesis, and Pharmacological Activity of the N-(4-(1H-1,2,4-Triazol-1-yl)phenyl)-substituted-amide Derivatives2025 · 2 citations
  3. 3Photoinduced Selective E / Z Isomerization and Site‐Selective C(sp 2 )–H Functionalization of Diaryl Methoximes2026
  4. 4Anticonvulsant activity of aza-Biginelli derivatives related to JM-II-43A and HSAB-based rationalization of their pharmacological profile2026
  5. 5Synthesis, In vivo, and In silico Evaluation of New Pyrazoline‐Benzothiazole Conjugates as Antiepileptic Agents2024 · 5 citations